Skip to main content
Erschienen in: Drug Safety 9/2015

01.09.2015 | Leading Article

Vaccine–Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms

verfasst von: Paolo Pellegrino, Cristiana Perrotta, Emilio Clementi, Sonia Radice

Erschienen in: Drug Safety | Ausgabe 9/2015

Einloggen, um Zugang zu erhalten

Abstract

Vaccinations are recommended throughout life to reduce the risk of vaccine-preventable diseases and their sequelae. Vaccines are often administered in patients with chronic diseases who are likely to be treated with several drugs. A growing number of clinical observations have indicated the possibility of interactions between vaccines and drugs, leading to changes in drug metabolism after vaccination. These interactions represent a significant concern because of the increasing use of vaccines in older patients who are likely to be treated with several drugs. Because of the possible implications of adverse reactions in terms of public health, several studies were performed to verify the risk posed by these interactions and to clarify the biologic mechanisms that drive these events. Of the several mechanisms proposed to be at the basis of vaccine–drug interactions, the most convincing evidence suggests a role of inflammatory cytokines on the regulation of specific cytochrome P450 enzymes in the liver. Differences in the cytochrome P450 enzymes involved in the metabolism of these drugs could explain these contrasting results and provide important insights to fully understand the clinical importance of these events. Further studies are required to verify whether vaccine–drug interactions may occur in other clinical settings, especially the ones for which patients are required to be vaccinated against specific diseases.
Literatur
1.
Zurück zum Zitat Bridges CB, Coyne-Beasley T. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older: United States, 2014. Ann Intern Med. 2014;160(3):190.CrossRefPubMed Bridges CB, Coyne-Beasley T. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older: United States, 2014. Ann Intern Med. 2014;160(3):190.CrossRefPubMed
2.
Zurück zum Zitat Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007–2008. NCHS Data Brief. 2010;(42):1–8. Gu Q, Dillon CF, Burt VL. Prescription drug use continues to increase: U.S. prescription drug data for 2007–2008. NCHS Data Brief. 2010;(42):1–8.
3.
Zurück zum Zitat Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. On the possible interaction between vaccines and drugs. Eur J Clin Pharmacol. 2014;70(3):369–71.CrossRefPubMed Pellegrino P, Carnovale C, Perrone V, Salvati D, Gentili M, Brusadelli T, et al. On the possible interaction between vaccines and drugs. Eur J Clin Pharmacol. 2014;70(3):369–71.CrossRefPubMed
4.
Zurück zum Zitat Pellegrino P, Clementi E, Radice S. Infections, vaccinations, drugs and interactions. Eur J Clin Pharmacol. 2014;70(7):891–2.CrossRefPubMed Pellegrino P, Clementi E, Radice S. Infections, vaccinations, drugs and interactions. Eur J Clin Pharmacol. 2014;70(7):891–2.CrossRefPubMed
5.
Zurück zum Zitat Pellegrino P, Carnovale C, Borsadoli C, Danini T, Speziali A, Perrone V, et al. Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol. Eur J Clin Pharmacol. 2013;69(8):1615–6.CrossRefPubMed Pellegrino P, Carnovale C, Borsadoli C, Danini T, Speziali A, Perrone V, et al. Two cases of hallucination in elderly patients due to a probable interaction between flu immunization and tramadol. Eur J Clin Pharmacol. 2013;69(8):1615–6.CrossRefPubMed
6.
Zurück zum Zitat D’Arcy PF. Vaccine-drug interactions. Drug Intell Clin Pharm. 1984;18(9):697–700.PubMed D’Arcy PF. Vaccine-drug interactions. Drug Intell Clin Pharm. 1984;18(9):697–700.PubMed
7.
Zurück zum Zitat Kramer P, McClain CJ. Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med. 1981;305(21):1262–4.CrossRefPubMed Kramer P, McClain CJ. Depression of aminopyrine metabolism by influenza vaccination. N Engl J Med. 1981;305(21):1262–4.CrossRefPubMed
8.
Zurück zum Zitat Goldstein RS, Cheung OT, Seguin R, Lobley G, Johnson AC. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J. 1982;126(5):470.PubMedCentralPubMed Goldstein RS, Cheung OT, Seguin R, Lobley G, Johnson AC. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J. 1982;126(5):470.PubMedCentralPubMed
9.
Zurück zum Zitat Renton KW, Gray JD, Hall RI. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J. 1980;123(4):288–90.PubMedCentralPubMed Renton KW, Gray JD, Hall RI. Decreased elimination of theophylline after influenza vaccination. Can Med Assoc J. 1980;123(4):288–90.PubMedCentralPubMed
10.
Zurück zum Zitat Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Radice S, et al. Efficacy of vaccination against influenza in patients with multiple sclerosis: the role of concomitant therapies. Vaccine. 2014;32(37):4730–5.CrossRefPubMed Pellegrino P, Carnovale C, Perrone V, Pozzi M, Antoniazzi S, Radice S, et al. Efficacy of vaccination against influenza in patients with multiple sclerosis: the role of concomitant therapies. Vaccine. 2014;32(37):4730–5.CrossRefPubMed
11.
Zurück zum Zitat Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arth Rheum. 2004;33(4):283–8.CrossRef Elkayam O, Caspi D, Reitblatt T, Charboneau D, Rubins JB. The effect of tumor necrosis factor blockade on the response to pneumococcal vaccination in patients with rheumatoid arthritis and ankylosing spondylitis. Semin Arth Rheum. 2004;33(4):283–8.CrossRef
12.
Zurück zum Zitat Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis. 2006;65(2):191–4.CrossRefPubMedCentralPubMed Fomin I, Caspi D, Levy V, Varsano N, Shalev Y, Paran D, et al. Vaccination against influenza in rheumatoid arthritis: the effect of disease modifying drugs, including TNF alpha blockers. Ann Rheum Dis. 2006;65(2):191–4.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology. 2006;45(1):106–11.CrossRefPubMed Kapetanovic MC, Saxne T, Sjoholm A, Truedsson L, Jonsson G, Geborek P. Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis. Rheumatology. 2006;45(1):106–11.CrossRefPubMed
14.
Zurück zum Zitat Robin C, Beckerich F, Cordonnier C. Immunization in cancer patients: where we stand. Pharmacol Res. 2015;92:23–30.CrossRefPubMed Robin C, Beckerich F, Cordonnier C. Immunization in cancer patients: where we stand. Pharmacol Res. 2015;92:23–30.CrossRefPubMed
16.
Zurück zum Zitat Pellegrino P, Clementi E, Capuano A, Radice S. Can vaccines interact with drug metabolism? Pharmacol Res. 2015;92:13–7.CrossRefPubMed Pellegrino P, Clementi E, Capuano A, Radice S. Can vaccines interact with drug metabolism? Pharmacol Res. 2015;92:13–7.CrossRefPubMed
18.
19.
Zurück zum Zitat Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol. 1993;67(2):171–7.CrossRefPubMed Ward BJ, Griffin DE. Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clin Immunol Immunopathol. 1993;67(2):171–7.CrossRefPubMed
20.
Zurück zum Zitat Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine. 1998;16(18):1722–31.CrossRefPubMed Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM. Cytokine production after influenza vaccination in a healthy elderly population. Vaccine. 1998;16(18):1722–31.CrossRefPubMed
21.
Zurück zum Zitat Pellegrino P, Capuano A, Radice S. On pharmacologist and vaccines: present and future challenges. Pharmacol Res. 2015;92:1.CrossRefPubMed Pellegrino P, Capuano A, Radice S. On pharmacologist and vaccines: present and future challenges. Pharmacol Res. 2015;92:1.CrossRefPubMed
23.
Zurück zum Zitat Chang KC, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet. 1978;1(8074):1132–3.CrossRefPubMed Chang KC, Bell TD, Lauer BA, Chai H. Altered theophylline pharmacokinetics during acute respiratory viral illness. Lancet. 1978;1(8074):1132–3.CrossRefPubMed
24.
Zurück zum Zitat Renton KW. Regulation of drug metabolism and disposition during inflammation and infection. Exp Opin Drug Metab Toxicol. 2005;1(4):629–40.CrossRef Renton KW. Regulation of drug metabolism and disposition during inflammation and infection. Exp Opin Drug Metab Toxicol. 2005;1(4):629–40.CrossRef
25.
Zurück zum Zitat Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B. In vivo effects of interleukin-10 on human cytochrome P450 activity. Clin Pharmacol Ther. 2000;67(1):32–43.CrossRefPubMed Gorski JC, Hall SD, Becker P, Affrime MB, Cutler DL, Haehner-Daniels B. In vivo effects of interleukin-10 on human cytochrome P450 activity. Clin Pharmacol Ther. 2000;67(1):32–43.CrossRefPubMed
26.
Zurück zum Zitat Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol. 1993;44(4):707–15.PubMed Abdel-Razzak Z, Loyer P, Fautrel A, Gautier JC, Corcos L, Turlin B, et al. Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture. Mol Pharmacol. 1993;44(4):707–15.PubMed
27.
Zurück zum Zitat Abdel-Razzak Z, Corcos L, Fautrel A, Campion JP, Guillouzo A. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol. 1994;46(6):1100–10.PubMed Abdel-Razzak Z, Corcos L, Fautrel A, Campion JP, Guillouzo A. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture. Mol Pharmacol. 1994;46(6):1100–10.PubMed
28.
Zurück zum Zitat Clark MA, Bing BA, Gottschall PE, Williams JF. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem Pharmacol. 1995;49(1):97–104.CrossRefPubMed Clark MA, Bing BA, Gottschall PE, Williams JF. Differential effect of cytokines on the phenobarbital or 3-methylcholanthrene induction of P450 mediated monooxygenase activity in cultured rat hepatocytes. Biochem Pharmacol. 1995;49(1):97–104.CrossRefPubMed
29.
Zurück zum Zitat Hayney MS, Muller D. Effect of influenza immunization on CYP3A4 activity in vivo. J Clin Pharmacol. 2003;43(12):1377–81.CrossRefPubMed Hayney MS, Muller D. Effect of influenza immunization on CYP3A4 activity in vivo. J Clin Pharmacol. 2003;43(12):1377–81.CrossRefPubMed
30.
Zurück zum Zitat Frye RF, Schneider VM, Frye CS, Feldman AM. Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. J Card Fail. 2002;8(5):315–9.CrossRefPubMed Frye RF, Schneider VM, Frye CS, Feldman AM. Plasma levels of TNF-alpha and IL-6 are inversely related to cytochrome P450-dependent drug metabolism in patients with congestive heart failure. J Card Fail. 2002;8(5):315–9.CrossRefPubMed
31.
Zurück zum Zitat Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Bbiophys Res Commun. 2002;293(1):145–9.CrossRef Beigneux AP, Moser AH, Shigenaga JK, Grunfeld C, Feingold KR. Reduction in cytochrome P-450 enzyme expression is associated with repression of CAR (constitutive androstane receptor) and PXR (pregnane X receptor) in mouse liver during the acute phase response. Biochem Bbiophys Res Commun. 2002;293(1):145–9.CrossRef
32.
Zurück zum Zitat Aitken AE, Morgan ET. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos. 2007;35(9):1687–93.CrossRefPubMedCentralPubMed Aitken AE, Morgan ET. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes. Drug Metab Dispos. 2007;35(9):1687–93.CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, et al. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem. 1997;272(38):23565–71.CrossRefPubMed Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, et al. Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR. J Biol Chem. 1997;272(38):23565–71.CrossRefPubMed
34.
Zurück zum Zitat Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 1998;92(1):73–82.CrossRefPubMed Kliewer SA, Moore JT, Wade L, Staudinger JL, Watson MA, Jones SA, et al. An orphan nuclear receptor activated by pregnanes defines a novel steroid signaling pathway. Cell. 1998;92(1):73–82.CrossRefPubMed
35.
Zurück zum Zitat Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest. 1998;102(5):1016–23.CrossRefPubMedCentralPubMed Lehmann JM, McKee DD, Watson MA, Willson TM, Moore JT, Kliewer SA. The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions. J Clin Invest. 1998;102(5):1016–23.CrossRefPubMedCentralPubMed
36.
Zurück zum Zitat Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Ann Rev Pharmacol Toxicol. 2006;46:123–49.CrossRef Aitken AE, Richardson TA, Morgan ET. Regulation of drug-metabolizing enzymes and transporters in inflammation. Ann Rev Pharmacol Toxicol. 2006;46:123–49.CrossRef
37.
Zurück zum Zitat Johnson EF, Palmer CN, Griffin KJ, Hsu MH. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 1996;10(11):1241–8.PubMed Johnson EF, Palmer CN, Griffin KJ, Hsu MH. Role of the peroxisome proliferator-activated receptor in cytochrome P450 4A gene regulation. FASEB J. 1996;10(11):1241–8.PubMed
38.
Zurück zum Zitat Gervois P, Vu-Dac N, Kleemann R, Kockx M, Dubois G, Laine B, et al. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem. 2001;276(36):33471–7.CrossRefPubMed Gervois P, Vu-Dac N, Kleemann R, Kockx M, Dubois G, Laine B, et al. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem. 2001;276(36):33471–7.CrossRefPubMed
39.
Zurück zum Zitat Richardson TA, Morgan ET. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J Pharmacol Exp Ther. 2005;314(2):703–9.CrossRefPubMed Richardson TA, Morgan ET. Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice. J Pharmacol Exp Ther. 2005;314(2):703–9.CrossRefPubMed
40.
Zurück zum Zitat McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176(10):6333–9.CrossRefPubMed McElhaney JE, Xie D, Hager WD, Barry MB, Wang Y, Kleppinger A, et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol. 2006;176(10):6333–9.CrossRefPubMed
41.
Zurück zum Zitat Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther. 2015;98(1):19–24.CrossRefPubMedCentralPubMed Birdwell KA, Decker B, Barbarino JM, Peterson JF, Stein CM, Sadee W, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 genotype and tacrolimus dosing. Clin Pharmacol Ther. 2015;98(1):19–24.CrossRefPubMedCentralPubMed
42.
Zurück zum Zitat Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015. doi:10.1002/cpt.147 [Epub ahead of print].PubMedCentralPubMed Hicks JK, Bishop JR, Sangkuhl K, Muller DJ, Ji Y, Leckband SG, et al. Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 and CYP2C19 genotypes and dosing of selective serotonin reuptake inhibitors. Clin Pharmacol Ther. 2015. doi:10.​1002/​cpt.​147 [Epub ahead of print].PubMedCentralPubMed
43.
Zurück zum Zitat Saito Y, Stamp LK, Caudle KE, Hershfield M, McDonagh EM, Callaghan JT, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharmacol Ther. 2015. doi:10.1002/cpt.161 [Epub ahead of print].PubMed Saito Y, Stamp LK, Caudle KE, Hershfield M, McDonagh EM, Callaghan JT, et al. Clinical pharmacogenetics implementation consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update. Clin Pharmacol Ther. 2015. doi:10.​1002/​cpt.​161 [Epub ahead of print].PubMed
44.
Zurück zum Zitat Haralambieva IH, Lambert ND, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, et al. Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination. PloS One. 2014;9(6):e99997.CrossRefPubMedCentralPubMed Haralambieva IH, Lambert ND, Ovsyannikova IG, Kennedy RB, Larrabee BR, Pankratz VS, et al. Associations between single nucleotide polymorphisms in cellular viral receptors and attachment factor-related genes and humoral immunity to rubella vaccination. PloS One. 2014;9(6):e99997.CrossRefPubMedCentralPubMed
45.
Zurück zum Zitat Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination. Hum Genet. 2014;133(11):1407–17.CrossRefPubMed Kennedy RB, Ovsyannikova IG, Haralambieva IH, Lambert ND, Pankratz VS, Poland GA. Genetic polymorphisms associated with rubella virus-specific cellular immunity following MMR vaccination. Hum Genet. 2014;133(11):1407–17.CrossRefPubMed
46.
Zurück zum Zitat Lambert ND, Haralambieva IH, Kennedy RB, Ovsyannikova IG, Pankratz VS, Poland GA. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination. J Infect Dis. 2015;211(6):898–905.CrossRefPubMed Lambert ND, Haralambieva IH, Kennedy RB, Ovsyannikova IG, Pankratz VS, Poland GA. Polymorphisms in HLA-DPB1 are associated with differences in rubella virus-specific humoral immunity after vaccination. J Infect Dis. 2015;211(6):898–905.CrossRefPubMed
47.
Zurück zum Zitat Ovsyannikova IG, Pankratz VS, Salk HM, Kennedy RB, Poland GA. HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study. Hum Genet. 2014;133(9):1083–92.CrossRefPubMedCentralPubMed Ovsyannikova IG, Pankratz VS, Salk HM, Kennedy RB, Poland GA. HLA alleles associated with the adaptive immune response to smallpox vaccine: a replication study. Hum Genet. 2014;133(9):1083–92.CrossRefPubMedCentralPubMed
48.
Zurück zum Zitat Ovsyannikova IG, Salk HM, Larrabee BR, Pankratz VS, Poland GA. Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines. Immunogenetics. 2014;66(11):663–9.CrossRefPubMed Ovsyannikova IG, Salk HM, Larrabee BR, Pankratz VS, Poland GA. Single-nucleotide polymorphism associations in common with immune responses to measles and rubella vaccines. Immunogenetics. 2014;66(11):663–9.CrossRefPubMed
49.
Zurück zum Zitat Pellegrino P, Clementi E, Radice S. Re: “Postelimination transmission of measles in the US”. Am J Epidemiol. 2014;180(4):452.CrossRefPubMed Pellegrino P, Clementi E, Radice S. Re: “Postelimination transmission of measles in the US”. Am J Epidemiol. 2014;180(4):452.CrossRefPubMed
50.
Zurück zum Zitat Pellegrino P, Falvella FS, Perrone V, Carnovale C, Brusadelli T, Pozzi M, et al. The first steps towards the era of personalised vaccinology: predicting adverse reactions. Pharmacogenomics J. 2014;15(3):284–7CrossRefPubMed Pellegrino P, Falvella FS, Perrone V, Carnovale C, Brusadelli T, Pozzi M, et al. The first steps towards the era of personalised vaccinology: predicting adverse reactions. Pharmacogenomics J. 2014;15(3):284–7CrossRefPubMed
51.
Zurück zum Zitat Falvella FS, Cheli S, Martinetti A, Mazzali C, Iacovelli R, Maggi C, et al. DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan. Br J Clin Pharmacol. 2015. doi:10.1111/bcp.12631 [Epub ahead of print].PubMed Falvella FS, Cheli S, Martinetti A, Mazzali C, Iacovelli R, Maggi C, et al. DPD and UGT1A1 deficiency in colorectal cancer patients receiving triplet chemotherapy with fluoropyrimidines, oxaliplatin and irinotecan. Br J Clin Pharmacol. 2015. doi:10.​1111/​bcp.​12631 [Epub ahead of print].PubMed
52.
Zurück zum Zitat Angelini S, Pantaleo MA, Ravegnini G, Zenesini C, Cavrini G, Nannini M, et al. Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy. Pharmacol Res. 2013;68(1):1–6.CrossRefPubMed Angelini S, Pantaleo MA, Ravegnini G, Zenesini C, Cavrini G, Nannini M, et al. Polymorphisms in OCTN1 and OCTN2 transporters genes are associated with prolonged time to progression in unresectable gastrointestinal stromal tumours treated with imatinib therapy. Pharmacol Res. 2013;68(1):1–6.CrossRefPubMed
53.
Zurück zum Zitat Barreiro P, Fernandez-Montero JV, de Mendoza C, Labarga P, Soriano V. Pharmacogenetics of antiretroviral therapy. Exp Opin Drug Metab Toxicol. 2014;10(8):1119–30.CrossRef Barreiro P, Fernandez-Montero JV, de Mendoza C, Labarga P, Soriano V. Pharmacogenetics of antiretroviral therapy. Exp Opin Drug Metab Toxicol. 2014;10(8):1119–30.CrossRef
54.
55.
Zurück zum Zitat Norata GD, Tibolla G, Catapano AL. Statins and skeletal muscles toxicity: from clinical trials to everyday practice. Pharmacol Res. 2014;88:107–13.CrossRefPubMed Norata GD, Tibolla G, Catapano AL. Statins and skeletal muscles toxicity: from clinical trials to everyday practice. Pharmacol Res. 2014;88:107–13.CrossRefPubMed
56.
Zurück zum Zitat Squassina A, Costa M, Congiu D, Manchia M, Angius A, Deiana V, et al. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol Res. 2013;73:1–7.CrossRefPubMed Squassina A, Costa M, Congiu D, Manchia M, Angius A, Deiana V, et al. Insulin-like growth factor 1 (IGF-1) expression is up-regulated in lymphoblastoid cell lines of lithium responsive bipolar disorder patients. Pharmacol Res. 2013;73:1–7.CrossRefPubMed
57.
Zurück zum Zitat Carroll DN, Carroll DG. Fatal intracranial bleed potentially due to a warfarin and influenza vaccine interaction. Ann Pharmacother. 2009;43(4):754–60.CrossRefPubMed Carroll DN, Carroll DG. Fatal intracranial bleed potentially due to a warfarin and influenza vaccine interaction. Ann Pharmacother. 2009;43(4):754–60.CrossRefPubMed
59.
Zurück zum Zitat Arnold WS, Mehta MK, Roberts JS. Influenza vaccine and anticoagulation control in patients receiving warfarin. Br J Clin Pract. 1990;44(4):136–9.PubMed Arnold WS, Mehta MK, Roberts JS. Influenza vaccine and anticoagulation control in patients receiving warfarin. Br J Clin Pract. 1990;44(4):136–9.PubMed
60.
Zurück zum Zitat Raj G, Kumar R, McKinney WP. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy. Arch Intern Med. 1995;155(14):1529–31.CrossRefPubMed Raj G, Kumar R, McKinney WP. Safety of intramuscular influenza immunization among patients receiving long-term warfarin anticoagulation therapy. Arch Intern Med. 1995;155(14):1529–31.CrossRefPubMed
61.
Zurück zum Zitat Poli D, Chiarugi L, Capanni M, Antonucci E, Abbate R, Gensini GF, et al. Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis. 2002;13(4):297–300.CrossRefPubMed Poli D, Chiarugi L, Capanni M, Antonucci E, Abbate R, Gensini GF, et al. Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis. 2002;13(4):297–300.CrossRefPubMed
62.
Zurück zum Zitat Iorio AM, Camilloni B, Basileo M, Guercini F, Conti S, Ferrante F, et al. Influenza vaccination in patients on long-term anticoagulant therapy. Vaccine. 2006;24(44–46):6624–8.CrossRefPubMed Iorio AM, Camilloni B, Basileo M, Guercini F, Conti S, Ferrante F, et al. Influenza vaccination in patients on long-term anticoagulant therapy. Vaccine. 2006;24(44–46):6624–8.CrossRefPubMed
63.
Zurück zum Zitat MacCallum P, Madhani M, Mt-Isa S, Ashby D. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin. Pharmacoepidemiol Drug Saf. 2007;16(7):786–9.CrossRefPubMed MacCallum P, Madhani M, Mt-Isa S, Ashby D. Lack of effect of influenza immunisation on anticoagulant control in patients on long-term warfarin. Pharmacoepidemiol Drug Saf. 2007;16(7):786–9.CrossRefPubMed
64.
Zurück zum Zitat Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA. Vaccine Safety Datalink i. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study. Pharmacoepidemiol Drug Saf. 2007;16(7):790–6.CrossRefPubMed Jackson ML, Nelson JC, Chen RT, Davis RL, Jackson LA. Vaccine Safety Datalink i. Vaccines and changes in coagulation parameters in adults on chronic warfarin therapy: a cohort study. Pharmacoepidemiol Drug Saf. 2007;16(7):790–6.CrossRefPubMed
65.
Zurück zum Zitat Paliani U, Filippucci E, Gresele P. Significant potentiation of anticoagulation by flu-vaccine during the season 2001–2002. Haematologica. 2003;88(5):599–600.PubMed Paliani U, Filippucci E, Gresele P. Significant potentiation of anticoagulation by flu-vaccine during the season 2001–2002. Haematologica. 2003;88(5):599–600.PubMed
66.
Zurück zum Zitat Aithal GP, Day CP, Kesteven PJ, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet. 1999;353(9154):717–9.CrossRefPubMed Aithal GP, Day CP, Kesteven PJ, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet. 1999;353(9154):717–9.CrossRefPubMed
67.
Zurück zum Zitat Levy RH. Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia. 1995;36(Suppl 5):S8–13.CrossRefPubMed Levy RH. Cytochrome P450 isozymes and antiepileptic drug interactions. Epilepsia. 1995;36(Suppl 5):S8–13.CrossRefPubMed
68.
Zurück zum Zitat Diaz RA, Sancho J, Serratosa J. Antiepileptic drug interactions. Neurologist. 2008;14(6 Suppl 1):S55–65.CrossRefPubMed Diaz RA, Sancho J, Serratosa J. Antiepileptic drug interactions. Neurologist. 2008;14(6 Suppl 1):S55–65.CrossRefPubMed
69.
Zurück zum Zitat Robertson WC Jr. Carbamazepine toxicity after influenza vaccination. Pediatr Neurol. 2002;26(1):61–3.CrossRefPubMed Robertson WC Jr. Carbamazepine toxicity after influenza vaccination. Pediatr Neurol. 2002;26(1):61–3.CrossRefPubMed
70.
Zurück zum Zitat Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, Schenker S. Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther. 1985;37(4):396–401.CrossRefPubMed Meredith CG, Christian CD, Johnson RF, Troxell R, Davis GL, Schenker S. Effects of influenza virus vaccine on hepatic drug metabolism. Clin Pharmacol Ther. 1985;37(4):396–401.CrossRefPubMed
71.
Zurück zum Zitat Fischer RG, Booth BH, Mitchell DQ, Kibbe AH. Influence of trivalent influenza vaccine on serum theophylline levels. Can Med Assoc J. 1982;126(11):1312–3.PubMedCentralPubMed Fischer RG, Booth BH, Mitchell DQ, Kibbe AH. Influence of trivalent influenza vaccine on serum theophylline levels. Can Med Assoc J. 1982;126(11):1312–3.PubMedCentralPubMed
72.
Zurück zum Zitat Gomolin IH, Chapron DJ, Luhan PA. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J Am Geriatr Soc. 1985;33(4):269–72.CrossRefPubMed Gomolin IH, Chapron DJ, Luhan PA. Lack of effect of influenza vaccine on theophylline levels and warfarin anticoagulation in the elderly. J Am Geriatr Soc. 1985;33(4):269–72.CrossRefPubMed
73.
Zurück zum Zitat Hamdy RC, Micklewright M, Beecham VF, Moore SW. Influenza vaccine may enhance theophylline toxicity: a case report and review of the literature. J Tennessee Med Assoc. 1995;88(12):463–4. Hamdy RC, Micklewright M, Beecham VF, Moore SW. Influenza vaccine may enhance theophylline toxicity: a case report and review of the literature. J Tennessee Med Assoc. 1995;88(12):463–4.
74.
Zurück zum Zitat Short CR, Horner MW, Blay PK, Moss MS, Edington N, Clarke CR. The lack of effect of inoculation with equine influenza vaccine on theophylline pharmacokinetics in the horse. J Vet Pharmacol Ther. 1986;9(4):426–32.CrossRefPubMed Short CR, Horner MW, Blay PK, Moss MS, Edington N, Clarke CR. The lack of effect of inoculation with equine influenza vaccine on theophylline pharmacokinetics in the horse. J Vet Pharmacol Ther. 1986;9(4):426–32.CrossRefPubMed
75.
Zurück zum Zitat Stults BM, Hashisaki PA. Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung disease. West J Med. 1983;139(5):651–4.PubMedCentralPubMed Stults BM, Hashisaki PA. Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung disease. West J Med. 1983;139(5):651–4.PubMedCentralPubMed
76.
Zurück zum Zitat Raaska K, Raitasuo V, Neuvonen PJ. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia. Eur J Clin Pharmacol. 2001;57(10):705–8.CrossRefPubMed Raaska K, Raitasuo V, Neuvonen PJ. Effect of influenza vaccination on serum clozapine and its main metabolite concentrations in patients with schizophrenia. Eur J Clin Pharmacol. 2001;57(10):705–8.CrossRefPubMed
77.
Zurück zum Zitat Pellegrino P, Falvella FS, Cheli S, Perrotta C, Clementi E, Radice S. The role of Toll-like receptor 4 polymorphisms in vaccine immune response. Pharmacogenom J. 2015. doi:10.1038/tpj.2015.21 Pellegrino P, Falvella FS, Cheli S, Perrotta C, Clementi E, Radice S. The role of Toll-like receptor 4 polymorphisms in vaccine immune response. Pharmacogenom J. 2015. doi:10.​1038/​tpj.​2015.​21
78.
Zurück zum Zitat Arango MT, Kivity S, Shoenfeld Y. Is narcolepsy a classical autoimmune disease? Pharmacol Res. 2015;92:6–12.CrossRefPubMed Arango MT, Kivity S, Shoenfeld Y. Is narcolepsy a classical autoimmune disease? Pharmacol Res. 2015;92:6–12.CrossRefPubMed
79.
Zurück zum Zitat Shoenfeld Y, Agmon-Levin N. ‘ASIA’: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8.CrossRefPubMed Shoenfeld Y, Agmon-Levin N. ‘ASIA’: autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. 2011;36(1):4–8.CrossRefPubMed
80.
Zurück zum Zitat Bailey M, Christoforidou Z, Lewis M. Evolution of immune systems: specificity and autoreactivity. Autoimmun Rev. 2013;12(6):643–7.CrossRefPubMed Bailey M, Christoforidou Z, Lewis M. Evolution of immune systems: specificity and autoreactivity. Autoimmun Rev. 2013;12(6):643–7.CrossRefPubMed
81.
Zurück zum Zitat Agmon-Levin N, Arango M-T, Kivity S, Katzav A, Gilburd B, Blank M, et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J Autoimmun. 2014;54:21–32.CrossRefPubMed Agmon-Levin N, Arango M-T, Kivity S, Katzav A, Gilburd B, Blank M, et al. Immunization with hepatitis B vaccine accelerates SLE-like disease in a murine model. J Autoimmun. 2014;54:21–32.CrossRefPubMed
82.
Zurück zum Zitat Chang C. Autoimmunity: from black water fever to regulatory function. J Autoimmun. 2014;48–49:1–9.CrossRefPubMed Chang C. Autoimmunity: from black water fever to regulatory function. J Autoimmun. 2014;48–49:1–9.CrossRefPubMed
83.
Zurück zum Zitat Colafrancesco S, Perricone C, Priori R, Valesini G, Shoenfeld Y. Sjögren’s syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). J Autoimmun. 2014;51:10–6.CrossRefPubMed Colafrancesco S, Perricone C, Priori R, Valesini G, Shoenfeld Y. Sjögren’s syndrome: another facet of the autoimmune/inflammatory syndrome induced by adjuvants (ASIA). J Autoimmun. 2014;51:10–6.CrossRefPubMed
84.
Zurück zum Zitat Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1–16.CrossRefPubMed Perricone C, Colafrancesco S, Mazor RD, Soriano A, Agmon-Levin N, Shoenfeld Y. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun. 2013;47:1–16.CrossRefPubMed
85.
Zurück zum Zitat Wang Q, Selmi C, Zhou X, Qiu D, Li Z, Miao Q, et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun. 2013;41:140–5.CrossRefPubMed Wang Q, Selmi C, Zhou X, Qiu D, Li Z, Miao Q, et al. Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun. 2013;41:140–5.CrossRefPubMed
86.
Zurück zum Zitat Esposito S, Prada E, Mastrolia MV, Tarantino G, Codeca C, Rigante D. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background. Immunol Res. 2014;60(2–3):366–75.CrossRefPubMed Esposito S, Prada E, Mastrolia MV, Tarantino G, Codeca C, Rigante D. Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues and pitfalls in the pediatric background. Immunol Res. 2014;60(2–3):366–75.CrossRefPubMed
87.
Zurück zum Zitat Meroni PL. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and a new syndrome? J Autoimmun. 2011;36(1):1–3.CrossRefPubMed Meroni PL. Autoimmune or auto-inflammatory syndrome induced by adjuvants (ASIA): old truths and a new syndrome? J Autoimmun. 2011;36(1):1–3.CrossRefPubMed
88.
Zurück zum Zitat Carvalho JF, Barros SM. ASIA or Shoenfeld’s syndrome: a novel autoimmune syndrome? Revista Brasileira de Reumatologia. 2010;50(5):487–8.CrossRefPubMed Carvalho JF, Barros SM. ASIA or Shoenfeld’s syndrome: a novel autoimmune syndrome? Revista Brasileira de Reumatologia. 2010;50(5):487–8.CrossRefPubMed
89.
Zurück zum Zitat Carvalho JF, Barros SM, Branco JC, Fonseca JE. Asia or Shoenfeld’s syndrome: highlighting different perspectives for diffuse chronic pain. Acta Reumatologica Portuguesa. 2011;36(1):10–2.PubMed Carvalho JF, Barros SM, Branco JC, Fonseca JE. Asia or Shoenfeld’s syndrome: highlighting different perspectives for diffuse chronic pain. Acta Reumatologica Portuguesa. 2011;36(1):10–2.PubMed
90.
Zurück zum Zitat Agmon-Levin N, Hughes GR, Shoenfeld Y. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’. Lupus. 2012;21(2):118–20.CrossRefPubMed Agmon-Levin N, Hughes GR, Shoenfeld Y. The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’. Lupus. 2012;21(2):118–20.CrossRefPubMed
91.
Zurück zum Zitat Remschmidt C, Wichmann O, Harder T. Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety. Vaccine. 2014;32(43):5585–92.CrossRefPubMed Remschmidt C, Wichmann O, Harder T. Influenza vaccination in HIV-infected individuals: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness and safety. Vaccine. 2014;32(43):5585–92.CrossRefPubMed
Metadaten
Titel
Vaccine–Drug Interactions: Cytokines, Cytochromes, and Molecular Mechanisms
verfasst von
Paolo Pellegrino
Cristiana Perrotta
Emilio Clementi
Sonia Radice
Publikationsdatum
01.09.2015
Verlag
Springer International Publishing
Erschienen in
Drug Safety / Ausgabe 9/2015
Print ISSN: 0114-5916
Elektronische ISSN: 1179-1942
DOI
https://doi.org/10.1007/s40264-015-0330-8

Weitere Artikel der Ausgabe 9/2015

Drug Safety 9/2015 Zur Ausgabe